help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BURMAN, W. J.
Right arrow Articles by JONES, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BURMAN, W. J.
Right arrow Articles by JONES, B. E.

Am. J. Respir. Crit. Care Med., Volume 164, Number 1, July 2001, 7-12

Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy

WILLIAM J. BURMAN and BRENDA E. JONES

Denver Public Health and the Department of Medicine (Division of Infectious Diseases), University of Colorado Health Sciences Center, Denver, Colorado; and Los Angeles County/University of Southern California Medical Center, Los Angeles, California

Keywords: tuberculosis; HIV infection; antiretroviral therapy; rifampin; rifabutin; protease inhibitor; drug-drug interactions; immune reconstitution




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
P. Price, D. M. Murdoch, U. Agarwal, S. R. Lewin, J. H. Elliott, and M. A. French
Immune Restoration Diseases Reflect Diverse Immunopathological Mechanisms
Clin. Microbiol. Rev., October 1, 2009; 22(4): 651 - 663.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. Khachi, R. O'Connell, D. Ladenheim, and C. Orkin
Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection
J. Antimicrob. Chemother., October 1, 2009; 64(4): 871 - 873.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
C. E. French, J. R. Glynn, M. E. Kruijshaar, I. C. Ditah, V. Delpech, and I. Abubakar
The association between HIV and antituberculosis drug resistance
Eur. Respir. J., September 1, 2008; 32(3): 718 - 725.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. D. Lawn, R. J. Wilkinson, M. C. I. Lipman, and R. Wood
Immune Reconstitution and "Unmasking" of Tuberculosis during Antiretroviral Therapy
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 680 - 685.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
R. E. Davaro and A. Thirumalai
Life-Threatening Complications of HIV Infection
J Intensive Care Med, March 1, 2007; 22(2): 73 - 81.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. Burman, D. Benator, A. Vernon, A. Khan, B. Jones, C. Silva, C. Lahart, S. Weis, B. King, B. Mangura, et al.
Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 350 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1169 - 1227.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Writing a Review Article for AJRCCM
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 732 - 734.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 603 - 662.
[Full Text] [PDF]

Home page
 ChestHome page
M. A. Judson
Highly Active Antiretroviral Therapy for HIV With Tuberculosis : Pardon the Granuloma
Chest, August 1, 2002; 122(2): 399 - 400.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M.D. Iseman
Tuberculosis therapy: past, present and future
Eur. Respir. J., July 1, 2002; 20(36_suppl): 87S - 94s.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R Colebunders and M L Lambert
Management of co-infection with HIV and TB
BMJ, April 6, 2002; 324(7341): 802 - 803.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, Interstitial Lung Disease, and Socioeconomic Issues in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 631 - 641.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. M. BECK, M. J. ROSEN, and H. H. PEAVY
Pulmonary Complications of HIV Infection . Report of the Fourth NHLBI Workshop
Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2120 - 2126.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society